Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Sars-cov-2 symbols : PFE save search
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease
Published: 2022-12-06 (Crawled : 12:20) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.13%
H: 0.37%
C: -1.88%
research program sars-cov-2
Pfizer Initiates Phase 1 Study of Novel Oral Antiviral Therapeutic Agent Against SARS-CoV-2
Published: 2021-03-23 (Crawled : 18:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.5%
H: 0.31%
C: -1.28%
phase 1 antiviral phase 3 phase 2 sars-cov-2
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
Published: 2021-02-17 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.32%
H: 0.28%
C: -0.63%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -4.9%
H: 5.19%
C: 4.31%
covid vaccine sars-cov-2 in vitro
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
Published: 2021-01-20 (Crawled : 13:01) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.16%
H: 0.05%
C: -0.79%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.28%
H: 1.04%
C: -1.13%
covid results vaccine antibody sars-cov-2
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
Published: 2021-01-08 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.27%
H: 0.98%
C: -0.08%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 4.71%
H: 3.16%
C: 2.33%
covid vaccine antibody sars-cov-2 in vitro
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.